Shengxiang Biotech announced that it recently received a court notice that part of the company's shares held by Chen Wenyi, a shareholder holding 5% or more of the shares, is to be judicially frozen and enforced. Chen Wenyi held 32.917,400 shares of the company, accounting for 5.68% of the total share capital. The court plans to judicially freeze 20.72 million unrestricted tradable shares under its name, and allow the applicant to sell no more than 4 million shares in batches through centralized bidding in the secondary market at the specified price. The period of reduction of holdings is not later than June 20, 2026. After enforcement, Chen Wenyi's shareholding fell to 289.17,400 shares, accounting for 4.99%. This matter does not affect the company's control and day-to-day operations.

Shengxiang Biotech announced that it recently received a court notice that part of the company's shares held by Chen Wenyi, a shareholder holding 5% or more of the shares, is to be judicially frozen and enforced. Chen Wenyi held 32.917,400 shares of the company, accounting for 5.68% of the total share capital. The court plans to judicially freeze 20.72 million unrestricted tradable shares under its name, and allow the applicant to sell no more than 4 million shares in batches through centralized bidding in the secondary market at the specified price. The period of reduction of holdings is not later than June 20, 2026. After enforcement, Chen Wenyi's shareholding fell to 289.17,400 shares, accounting for 4.99%. This matter does not affect the company's control and day-to-day operations.